Nr. Crt. | Nume | Status | Locatie |
1. | A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer | In curs de recrutare | Centrul de Oncologie Sf. Nectarie SRL Craiova, Dolj, Romania, 200347 Contact 40351401336 Principal Investigator: Michael Schenker S.C. R.T.C. Radiology Therapeutic Center S.R.L. Otopeni, Ilfov, Romania, 075100 Contact 40372744344 Principal Investigator: Elena Ciubotaru SC Gral Medical SRL Bucuresti, Romania, 031422 Contact 40213230000 Principal Investigator: Cristina Tiut Spitalul Clinic Judetean de UrgentaSf.Apostol Andrei Constanta Constanta, Romania, 900591 Contact 40241662222 Principal Investigator: Laura Mazilu |
2. | A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer | In curs de recrutare | Local Institution Not yet recruiting Craiova, Dolj, Romania, 200347 Contact: Site 0052 Local Institution Not yet recruiting Bucharest, Romania, 022328 Contact: Site 0042 Local Institution Not yet recruiting Cluj Napoca, Romania, 400015 Contact: Site 0041 Local Institution Not yet recruiting Cluj Napoca, Romania, 400015 Contact: Site 0043 Local Institution Not yet recruiting Constanta, Romania, 900591 Contact: Site 0020 Local Institution Not yet recruiting Timisoara, Romania, 300239 Contact: Site 0035 |
3. | Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy | In curs de recrutare | Sf. Constantin Hospital; Oncology Completed Brasov, Romania, 500019 Prof. Dr. Th. Burghele Clin Urology Hosp Active, not recruiting Bucharest, Romania, 050659 Prof. Dr. I. Chiricuta Institute of Oncology Completed Cluj Napoca, Romania, 400015 Institute of Oncology „Prof. Dr. I. Chiricuta” Not yet recruiting Cluj-Napoca, Romania, 400015 ONCOMED – Medical Centre Completed Timisoara, Romania, 300239 Municipal Hosp Turdal; Oncology Completed Turda, Romania, 401103 |
4. | A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) | Activ, inca nu recruteaza | Site RO40008 Cluj-Napoca, Cluj, Romania Site RO40009 Cluj-Napoca, Cluj, Romania Site RO40002 Floresti, Cluj, Romania Site RO40011 Timisoara, Timis, Romania Site RO40007 Brasov, Romania Site RO40003 Bucharest, Romania Site RO40006 Bucharest, Romania |
5. | An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS | Activ, inca nu recruteaza | Bucuresti, Romania Cluj-Napoca, Romania Floresti, Romania Iasi, Romania Otopeni, Romania Ploiesti, Romania Sibiu, Romania TarguMures, Romania Timisoara, Romania |
6. | A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer | Activ, inca nu recruteaza | Baia Mare, Romania Brasov, Romania Bucharest, Romania Cluj- Napoca, Romania TarguMures, Romania |
7. | Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Nonmetastatic Castration-resistant Prostate Cancer | Activ, inca nu recruteaza | Bucuresti, Romania, 22328 Bucuresti, Romania, 41345 Bucuresti, Romania, 50659 Bucuresti, Romania, 75000 Cluj-Napoca, Romania, 400015 Craiova, Romania, 200385 Craiova, Romania, 200642 Oradea, Romania, 410159 Ploiesti, Romania, 100337 Targu-Mures, Romania, 540103 |
8. | A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC | Activ, inca nu recruteaza | Bucharest, Romania Cluj Napoca, Romania Craiova, Romania TarguMures, Romania |
9. | A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer | Activ, inca nu recruteaza | Sc Radiotherapy Center Cluj SRL Cluj, Romania |
10. | A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) | Activ, inca nu recruteaza | Brasov, Romania Bucharest, Romania Bucuresti, Romania Cluj Napoca, Romania Iasi, Romania |
11 | A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer | Activ, inca nu recruteaza | Arensia Exploratory Medicine Bucharest, Romania, 21105 |